WITHDRAWN: A targeted mass-spectrometry plasma proteome for simultaneous multi-disease screening

Imagine your body as a bustling, high-tech city. Every day, millions of tiny messengers called proteins zip through the bloodstream, delivering notes about what's happening in different neighborhoods. Some messengers say, "All clear in the heart district!" while others might whisper, "Hey, there's a little trouble brewing in the liver." For a long time, doctors had to send out separate teams to check each neighborhood one by one, which was slow and expensive. But what if you could send out one super-scout that could read all the messages at once? That's the dream behind a field called plasma proteomics. Think of "plasma" as the river that carries these messengers, and "proteomics" as the art of reading their notes. Scientists have been building better and better "scanners" to read these notes, hoping to catch diseases early, before they turn into big, scary monsters. The big question everyone is asking is: Can we build a single scanner that checks for many different diseases at the same time, without getting confused?

This specific paper, titled "A targeted mass-spectrometry plasma proteome for simultaneous multi-disease screening," was supposed to be the answer to that question. The authors, a team of researchers from universities in South Korea, set out to create a special "targeted" list of protein messengers. They wanted to use a high-tech tool called mass spectrometry—think of it as a super-precise scale that weighs and identifies these tiny protein notes—to scan blood samples and see if they could spot signs of multiple different diseases all at once. It sounds like the perfect setup for a medical superhero gadget.

However, there is a twist in the story. The paper you are looking at is actually a ghost. The authors have officially withdrawn the manuscript. Before they could share their findings with the world, an administrative hiccup occurred regarding "co-author consent." In the world of science, everyone who helps write a paper needs to agree to put their name on it, especially when posting it online before it's been fully checked by other experts (a step called peer review). Because this agreement wasn't sorted out before the paper was posted, the team decided to pull the plug.

So, what does this mean for the science? The paper does not contain any findings to explain. It does not tell us if they successfully built their multi-disease scanner, nor does it tell us if the scanner worked or failed. The authors explicitly state that because of this consent issue, they do not want this work to be cited or used as a reference for any project. In short, the story ends before the main event. The "super-scout" was never fully introduced, and the results of the multi-disease screening remain a mystery in this document. The only thing we know for sure is that the authors, for reasons of procedure and agreement, have asked us to forget this specific draft ever existed.